Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2012-06-22Clinical Trial Update: Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
A compassionate-use study of pergolide for Parkinson's disease is no longer available.
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Effect of BIA 9-1067 on Cardiac Repolarization in Healthy Adult Men and Women [Phase 1]
Phase 1 clinical trial update evaluating the effect of BIA 9-1067 on cardiac repolarization in healthy adults.
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients [Phase 2]
Phase 2 dose-range study evaluating BF2.649 versus placebo in Parkinson's disease patients with excessive daytime sleepiness has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-07Clinical Trial Update: Trichloroethylene (TCE) Exposure in an Industrial Population
A completed University of Kentucky clinical trial evaluated exposure to trichloroethylene in an industrial population and assessed potential…
-
FDA approval · 2012-06-06FDA Approved: ROPINIROLE — Original Application (Dr. Reddys Laboratories Limited)
FDA approved Dr. Reddy's Laboratories Limited's generic ropinirole tablets via an original ANDA. Ropinirole is used to treat Parkinson's dis…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-06-05FDA Approved: AMANTADINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for amantadine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.
-
CLINICAL_TRIALS trial_result · 2012-05-28Clinical Trial Update: Evaluation of the Tolerance and Acceptability of Rasagiline in the Treatment of Early-stage Parkinson's Disease [Phase 4]
Phase 4 trial evaluating the tolerability and acceptability of rasagiline for early-stage Parkinson's disease was terminated.
-
CLINICAL_TRIALS research · 2012-05-24Clinical Trial Update: Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists [Phase 3]
A Phase 3 clinical trial evaluating piribedil (Clarium) versus other non-ergot dopamine agonists in Parkinson's disease, focusing on vigilan…
-
CLINICAL_TRIALS trial_result · 2012-05-21Clinical Trial Update: Long-term Administration Study of SND 919 Tablets in Parkinson's Disease [Phase 3]
Boehringer Ingelheim's Phase 3 long-term administration study of SND 919 tablets in Parkinson's disease has completed.
-
FDA approval · 2012-05-17FDA Approved: ROPINIROLE — Original Application (Actavis Pharma, Inc.)
The FDA approved Actavis Pharma, Inc.'s original application for ropinirole, a generic formulation used to treat Parkinson's disease and res…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Lubiprostone as a Treatment for Constipation in Parkinson's Disease [NA]
A terminated clinical trial examined lubiprostone for constipation in people with Parkinson's disease; results were posted in May 2012.
-
FDA approval · 2012-05-14FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for a generic carbidopa-levodopa product manufactured by Mylan Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2012-05-10Clinical Trial Update: Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [Phase 2, Phase 3]
A Phase 2/3 trial evaluating CEP-1347 for Parkinson's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) and Parkinson's Disease [NA]
A completed clinical trial evaluating transcranial direct current stimulation (tDCS) for Parkinson's disease with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease [Phase 3]
Phase 3 clinical trial evaluating the nutritional supplement VIUSID/ALZER in Parkinson's disease has completed.
-
CLINICAL_TRIALS other · 2012-05-02Clinical Trial Update: Emotional and Cognitive Subthalamic Nucleus in Deep Brain Stimulation Treated Parkinson Patients
An update on a clinical trial evaluating emotional and cognitive effects of subthalamic nucleus deep brain stimulation in Parkinson's diseas…
-
CLINICAL_TRIALS withdrawal · 2012-04-30Clinical Trial Update: Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off [Phase 4]
A Phase 4 trial comparing carbidopa/levodopa with and without entacapone in Parkinson's disease was withdrawn; no results are available.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Study of Methylphenidate to Treat Gait Disorders And Attention Deficit In Parkinson's Disease (PARKGAIT-II) [Phase 4]
Phase 4 PARKGAIT-II trial assessing methylphenidate for gait disturbances and attention deficits in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-24Clinical Trial Update: Study of Rivastigmine to Treat Parkinsonian Apathy Without Dementia [Phase 3]
A Phase 3 trial studied rivastigmine for Parkinsonian apathy in patients without dementia and has completed. The snippet does not include tr…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Functional Improvement in Patients With Parkinson's Disease After Training in Real or Virtual Environment [NA]
A completed clinical trial reported functional improvement in Parkinson's disease patients following training in real or virtual environment…
-
CLINICAL_TRIALS trial_result · 2012-04-19Clinical Trial Update: Computer-Based Balance Training for People With Parkinson's Disease [Phase 2]
A Phase 2 clinical trial evaluating computer-based balance training for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-04Clinical Trial Update: Masked Faces in Parkinson Disease: Mechanism and Treatment [Phase 2]
Phase 2 clinical trial from the University of Florida explored the mechanism and potential treatment of masked faces in Parkinson's disease;…
-
FDA approval · 2012-04-02FDA Approved: NEUPRO — Supplemental Application (UCB, Inc.)
The FDA approved a supplemental application for NEUPRO (rotigotine) from UCB, Inc.
-
CLINICAL_TRIALS research · 2012-03-27Clinical Trial Update: Memory Disorders Registry
The Memory Disorders Registry study is reported as completed, with conditions including dementia, Alzheimer's disease, Parkinson's disease, …
-
CLINICAL_TRIALS trial_result · 2012-03-26Clinical Trial Update: Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease [Phase 4]
This clinical trial update reports the completion of a Phase 4 study evaluating memantine for gait disorders and attention deficits in Parki…